Willis Towers Watson Public Limited Company (WTW) Q3 2025 Earnings Call Transcript
Willis Towers Watson Public Limited Company ( WTW ) Q3 2025 Earnings Call October 30, 2025 9:00 AM EDT Company Participants Carl A. Hess - CEO & Director Andrew Krasner - CFO & Co-head of Corporate Development Lucy Clarke - President of Risk & Broking Julie Gebauer - President of Health, Wealth & Career Conference Call Participants Charles Peters - Raymond James & Associates, Inc., Research Division Elyse Greenspan - Wells Fargo Securities, LLC, Research Division Robert Cox - Goldman Sachs Group, Inc., Research Division Michael Zaremski - BMO Capital Markets Equity Research Jon Paul Newsome - Piper Sandler & Co., Research Division David Motemaden - Evercore ISI Institutional Equities, Research Division Mark Hughes - Truist Securities, Inc., Research Division Ryan Tunis - Cantor Fitzgerald & Co., Research Division Mark Marcon - Robert W.
Willis Towers Q3 Earnings Beat Estimates on Lower Expenses
WTW's Q3 results reflect strong revenue contributions from the Risk & Broking segment, expanded operating margin and reduced expenses.
Willis Towers Watson (WTW) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Willis Towers Watson (WTW) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Seeking Clues to Willis Towers Watson (WTW) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Willis Towers Watson (WTW), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.
Willis Towers Gears Up to Report Q3 Earnings: Here's What to Expect
WTW's Q3 performance is likely to have benefited from geographic expansion, strong client retention, and new business activity.
Willis Towers Watson (WTW) is a Great Momentum Stock: Should You Buy?
Does Willis Towers Watson (WTW) have what it takes to be a top stock pick for momentum investors? Let's find out.
All You Need to Know About Willis Towers Watson (WTW) Rating Upgrade to Buy
Willis Towers Watson (WTW) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
WTW Poised for Growth Amid Margin Pressures and FX Challenges
Willis Towers Watson benefits from efficiency, growth in key segments and stronger shareholder returns.
Willis Towers Trades Above 50-Day SMA: How to Play the Stock?
WTW drives growth with efficiency and a client-focused approach but rising costs and foreign exchange risks pressure margins.
Can Willis Tower's Gemini Redefine How Insurers Manage Complex Risks?
WTW launches Gemini, a digital insurance platform designed to simplify complex risks, cut costs, and boost client confidence.
Willis Towers Watson: Margins Expanding But Growth Faces Pressure
Willis Towers Watson delivered solid Q2 results with margin expansion and strong cost discipline, alleviating some sector concerns and driving a 5% stock jump. Organic revenue growth remains healthy at 5%, but premium inflation is normalizing, likely slowing future growth to mid-single digits. The company maintains a strong balance sheet, prioritizes aggressive buybacks, and is on track for $1.5 billion in repurchases this year.
Willis Towers Watson Public Limited Company (WTW) Q2 2025 Earnings Call Transcript
Willis Towers Watson Public Limited Company (NASDAQ:WTW ) Q2 2025 Earnings Conference Call July 31, 2025 9:00 AM ET Company Participants Andrew Jay Krasner - CFO & Co-head of Corporate Development Carl A. Hess - CEO & Director Julie Jarecke Gebauer - President of Health, Wealth & Career Lucy Clarke - President of Risk & Broking Conference Call Participants Brian Robert Meredith - UBS Investment Bank, Research Division Charles Lederer - Unidentified Company Elyse Beth Greenspan - Wells Fargo Securities, LLC, Research Division Katherine Sakys - Unidentified Company Mark Douglas Hughes - Truist Securities, Inc., Research Division Mark Steven Marcon - Robert W.
